Save time and get answers to complex questions with AI chat
When is xarelto's patent set to expire roughly?Is clarinex off patent?Dabrafenib mesylate when the patent is expiring in india?Xenazine current manufacturer 2025?Is allopurinol expensive?
See the DrugPatentWatch profile for vyvanse
Vyvanse (lisdexamfetamine dimesylate) is a prodrug of dextroamphetamine. Its metabolism works this way: - Activation: After oral intake, lisdexamfetamine is cleaved in the body to release the active drug, dextroamphetamine, plus the amino acid lysine. - Where it happens: The conversion is done mainly by enzymes in red blood cells (a hydrolysis/amide bond cleavage). This makes the onset gradual and prolongs the effect. - Hepatic metabolism: Vyvanse is not significantly metabolized by the liver’s cytochrome P450 system. There is minimal hepatic metabolism; most of the activity comes from the red blood cell–mediated conversion. - Excretion: The active dextroamphetamine and the lysine moiety are excreted in the urine. The drug's effects last longer than immediate-acting amphetamines because of the slow prodrug conversion. - Practical notes: Vyvanse can be taken with or without food; absorption is not highly dependent on meals. In short: Vyvanse is a prodrug that is slowly converted to dextroamphetamine in the blood, not by liver metabolism, with elimination via the kidneys.
Other Questions About Vyvanse :